Researchers from the US have shown that combination therapy with sitagliptin and metformin results in a substantial and additive glycemic improvement in patients with type 2 diabetes. Sitagliptin ...

Initial combination therapy with a DPP-4 inhibitor, sitagliptin and metformin (Janumet™), was recently approved by the US FDA, and clinically relevant and sustained reductions of fasting plasma ...

NPPA fixes retail price of 42 formulations, revise prices based on review orders: Our Bureau, New Delhi Tuesday, February 11, 2025, 13:30 Hrs [IST] The National Pharmaceutical Pri ...

Nectar Life Care has announced the launch of a new range of high-quality, cost-effective anti-diabetic formulations, with dapagliflozin under the brand name Dapnec. With the expiration of API patents, ...

The combination of sitagliptin and metformin provided a more than additive effect on native GLP-1 concentrations. This combination may benefit patients with Type 2 diabetes through substantial ...

triple drug fixed dose combination (FDC) of Dapagliflozin, Sitagliptin and Metformin under the brand name of Dapanorm Trio ® at an affordable price for adults with Type 2 Diabetes in India.

A study from The BMJ found 44% of participants reversed type 2 diabetes with a calorie-restricted diet and dapagliflozin ... diabetic medications. The combination strategy also improved weight ...

The 42 formulations under review include a number of anti-diabetes combination medicines like Sitagliptin, Dapagliflozin, Glimepiride, Metformin Hydrochloride, and Empagliflozin, among others.

Zituvio and combination products include Zituvio™ (sitagliptin), Zituvimet™ (sitagliptin and metformin hydrochloride) and Zituvimet™ XR (sitagliptin and metformin hydrochloride ...